Search results for “Milbemycin oxime” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 66 patents, we discovered top 36 key players by total patent application. Virbac SA, Novartis AG, Pharmaq AS are dominant in this area. They take 22.73% of the total patent filing.
Virbac SA
France
Patent: 7
Novartis AG
Basel-Stadt, Switzerland
Patent: 4
Pharmaq AS
Oslo, Norway
Patent: 4
Hubei Honch Pharmaceutical Co., Ltd.
Hubei Sheng, China
Patent: 4
Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc.
Guangdong Sheng, China
Patent: 3
Zhejiang Hisun Animal Health Products Co., Ltd.
Zhejiang Sheng, China
Patent: 3
FMC Corp.
Pennsylvania, United States
Patent: 2
Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 2
Sankyo Co., Ltd.
Tokyo-to, Japan
Patent: 2
Elanco Tiergesundheit AG
Basel-Stadt, Switzerland
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 18 patents applied in the last 5 years. We discover 10 most active companies in this area. The fast-growing Pharmaq AS, Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc., Zhejiang Hisun Animal Health Products Co., Ltd. take 55.56% of patent filing during this period.
Pharmaq AS
Oslo, Norway
Patent: 4
Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc.
Guangdong Sheng, China
Patent: 3
Zhejiang Hisun Animal Health Products Co., Ltd.
Zhejiang Sheng, China
Patent: 3
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Fujian Sheng, China
Patent: 2
Ruipu Tianjin Biology Pharmaceutical Co. Ltd.
Tianjin Shi, China
Patent: 1
Sichuan Agricultural University
Sichuan Sheng, China
Patent: 1
Nanjing Longbott Animal Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Shang Hai Fan Tai Ke Hua Gong You Xian Gong Si
Shanghai Shi, China
Patent: 1
China Conservation and Research Center for Giant Pandas
undefined undefined
Patent: 1
Tarim University
Xinjiang Uygur Zizhiqu, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 18 patents in last 5 years, we discover 9 new entrants. Pharmaq AS, Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc., Zhejiang Hisun Animal Health Products Co., Ltd. are the most active new entrants in this area.
Pharmaq AS
Oslo, Norway
Patent: 4
Livzon Group Xinbeijiang Pharmaceutical Manufacturing Inc.
Guangdong Sheng, China
Patent: 3
Zhejiang Hisun Animal Health Products Co., Ltd.
Zhejiang Sheng, China
Patent: 3
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Fujian Sheng, China
Patent: 2
Sichuan Agricultural University
Sichuan Sheng, China
Patent: 1
Nanjing Longbott Animal Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Shang Hai Fan Tai Ke Hua Gong You Xian Gong Si
Shanghai Shi, China
Patent: 1
China Conservation and Research Center for Giant Pandas
undefined undefined
Patent: 1
Tarim University
Xinjiang Uygur Zizhiqu, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 5 universities and scientific research institutions by total patent application. Sichuan Agricultural University, Wuhan University, Northwest A&F University are dominant in this area. They take 50.00% of the total patent filing.
Sichuan Agricultural University
Sichuan Sheng, China
Patent: 1
Wuhan University
Hubei Sheng, China
Patent: 1
Northwest A&F University
Shaanxi Sheng, China
Patent: 1
Northeast Agricultural University
Heilongjiang Sheng, China
Patent: 1
Tarim University
Xinjiang Uygur Zizhiqu, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: